Transcriptome analysis identifies genetic architecture and potential therapeutic targets for Graves' ophthalmopathy, suggesting new avenues for treatment.
Our findings highlight the genetic architecture of GO, identifying ZSCAN9 and HLA - DMA as potential causal genes, and underscore the importance of integrating multi-omics data to unravel complex disease mechanisms. Subsequent investigations ought to concentrate on corroborating these results and identifying potential therapeutic targets for GO.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: